Immuto Scientific
Seed Round in 2021
Immuto Scientific is a biotechnology services company that specializes in providing analytical insights to pharmaceutical firms engaged in drug discovery. The company has developed a protein footprinting technology that automates the complex analysis of proteins, an essential component of the drug development process. This innovative technology offers a faster alternative to the industry-standard techniques for protein structure analysis, allowing drug developers to ascertain protein structures more efficiently. By streamlining these analytical processes, Immuto Scientific enhances the overall effectiveness of drug discovery efforts, particularly for protein therapeutics.
AIQ Solutions
Series A in 2019
AIQ Solutions, Inc. is a Madison, Wisconsin-based company that specializes in designing and developing medical devices and software solutions aimed at the quantitative assessment of lesions associated with complex diseases, particularly cancer. Established in 2015, the company offers a clinical decision support platform that analyzes medical imaging data to identify and quantify cancer lesions, evaluating changes post-treatment. Its key products include quantitative total bone imaging (QTBI), which provides insights into metastatic bone disease, and quantitative total marrow imaging (QTMI), which assesses heterogeneity and treatment response in bone marrow. AIQ Solutions primarily serves oncologists, radiologists, nuclear medicine physicians, and pharmaceutical companies. The company leverages patented methodologies developed from extensive research and funding, enhancing the evaluation of treatment responses and ultimately improving patient outcomes while aiming to reduce healthcare costs.
HealthMyne
Venture Round in 2016
HealthMyne, Inc. is a healthcare informatics company based in Madison, Wisconsin, specializing in innovative search, analytics, and imaging solutions tailored for cancer care providers. Founded in 2013, the company aims to enhance clinical decision-making by offering real-time, evidence-based imaging insights that support optimized patient care and reduce delivery costs. HealthMyne's technology enables physicians to manipulate tumor images and access electronic health records and image repositories, facilitating the diagnosis and treatment of similar cases. The company’s platform also focuses on improving patient management through features such as automatic tumor staging, dose overlays, and specialized reporting, which streamline clinical workflows and support precision medicine initiatives.
Swallow Solutions
Debt Financing in 2016
Swallow Solutions, LLC is a company based in Madison, Wisconsin, dedicated to addressing swallowing disorders, also known as dysphagia, in the United States. Founded in 2004, the company specializes in developing therapeutic devices and nutritional food products tailored to the specific needs of patients based on their diagnosed level of swallowing difficulty. One of its notable offerings is SwallowSTRONG, which features a custom-molded mouthpiece combined with software that enables speech-language pathologists to implement an evidence-based therapy regimen aimed at improving lingual strength. Additionally, Swallow Solutions provides a cloud-based management system that allows clinicians to remotely monitor patients' progress, adjust therapy parameters, and analyze therapy data. Through these innovative solutions, Swallow Solutions aims to enhance the quality of life for individuals with swallowing difficulties.
Carson Life
Venture Round in 2016
Carson Life, Inc. is a Miami Beach-based company specializing in the manufacturing and supply of natural health and beauty products. Founded in 2015, it focuses on the Hispanic market and offers a diverse range of products, including those for weight loss, hair care, skin care, anti-aging, and vitamins. The company is known for its exclusive endorsement deals with prominent celebrities in the Hispanic community, which enhances its brand visibility. Carson Life's products are available through a wide distribution network, including over 7,000 retail locations such as Walmart, Walgreens, HEB, Target, and CVS, as well as through its webshop and major e-commerce platforms like Amazon. The company emphasizes eco-friendly practices in its offerings, aiming to provide customers with sustainable options that promote health and wellness.
FluGen
Venture Round in 2016
FluGen, Inc. is a biopharmaceutical company based in Madison, Wisconsin, focused on developing vaccines to prevent diseases caused by influenza viruses. Founded in 2007, FluGen specializes in both seasonal and pandemic influenza prevention. The company offers RedeeFlu, a nasal spray vaccine, and utilizes a vaccine-loaded intradermal microneedle delivery device. FluGen's innovative approach includes the use of a live, single replication, intranasally delivered virus with a deleted M2 segment (M2SR), enhancing its ability to prevent the spread of influenza and other respiratory pathogens, including COVID-19.
Invenra
Venture Round in 2016
Invenra Inc. is a biotechnology company based in Madison, Wisconsin, specializing in the discovery of biologics, particularly focusing on antibodies and their derivatives. Founded in 2011, Invenra employs a proprietary technology that integrates cell-free expression of full-length antibodies with extreme miniaturization. This innovative approach allows for the screening of an unprecedented number of full-length antibodies in phenotypic assays. The company's platform is designed to facilitate the development and optimization of human multi-specific antibodies, with applications in treating diseases such as cancer, Alzheimer's, and diabetes. Invenra's team comprises scientists with extensive expertise across various disciplines, including genomics, biochemistry, and bioengineering, ensuring a strong foundation in both fundamental research and practical applications.
NeuWave Medical
Series C in 2015
NeuWave Medical is a company based in Madison, Wisconsin, that specializes in the development of energy-based minimally invasive medical devices. Founded in 2004 by a team of engineers and physician-scientists, NeuWave Medical is dedicated to addressing clinical needs through innovative solutions that are both effective and minimally invasive. The company aims to create high-quality devices that are preferred by leading physicians and medical centers worldwide, focusing on treating a variety of serious medical conditions.
Sitka Salmon Shares
Seed Round in 2015
Sitka Salmon Shares is a community-supported fishery delivering premium, blast-frozen, wild seafood shares to members in the lower 48. It connects its collective of 20 small boat family fishermen-owners with their over 5,000 member Community Supported Fishery and network of regional partners.
Swallow Solutions
Venture Round in 2015
Swallow Solutions, LLC is a company based in Madison, Wisconsin, dedicated to addressing swallowing disorders, also known as dysphagia, in the United States. Founded in 2004, the company specializes in developing therapeutic devices and nutritional food products tailored to the specific needs of patients based on their diagnosed level of swallowing difficulty. One of its notable offerings is SwallowSTRONG, which features a custom-molded mouthpiece combined with software that enables speech-language pathologists to implement an evidence-based therapy regimen aimed at improving lingual strength. Additionally, Swallow Solutions provides a cloud-based management system that allows clinicians to remotely monitor patients' progress, adjust therapy parameters, and analyze therapy data. Through these innovative solutions, Swallow Solutions aims to enhance the quality of life for individuals with swallowing difficulties.
Madison Vaccines
Series A in 2015
Madison Vaccines, Inc. is a biopharmaceutical company based in the United States that specializes in the development of therapeutic plasmid DNA vaccines, specifically targeting prostate cancer and bone metastases. The company is engaged in creating two distinct vaccines aimed at treating prostate cancer and is also developing a diagnostic test to identify patients who would benefit from these therapies. Madison Vaccines' immune-activating therapies are designed to stimulate the immune system to eradicate residual tumor cells before they progress to overt bone metastases, thus delaying the need for castration therapies and improving the chances of a cure at an early stage of the disease.
Phoenix
Debt Financing in 2015
Phoenix, LLC, established in 2005 and headquartered in Madison, Wisconsin, specializes in designing and manufacturing high-yield neutron generators and other commercial nuclear technologies. These products cater to diverse applications across industries such as aerospace, defense, medical, and semiconductor, including neutron radiography, cargo screening, medical isotope production, and nuclear fuel scanning. The company's commitment to practical nuclear technologies has also set a long-term goal of contributing to clean, fusion energy production.
Ultravisual
Venture Round in 2015
Ultravisual is a visual network based in Brooklyn, NY, dedicated to fostering inspiration, expression, and collaboration among users. The company provides a content-sharing platform that enables individuals to share visual content in an organized manner, tailored to their interests. By leveraging mobile technology, Ultravisual enhances the way people communicate and express themselves through images and videos, transforming everyday content into aesthetically pleasing experiences. Its mission is to facilitate visual communication, reflecting the growing importance of imagery in personal and social interactions. With strategic backing from Technicolor, Ultravisual aims to evolve how users engage and connect within a visually-driven landscape.
Silatronix
Funding Round in 2015
Silatronix, Inc. is a company that specializes in the development of organosilicon compounds and formulations for energy storage applications. Founded in 2007 and based in Madison, Wisconsin, Silatronix focuses on creating organosilicon electrolytes designed for use in rechargeable and non-rechargeable lithium-ion batteries, as well as in ultracapacitors. The company's patented materials enhance battery performance by extending cell life, increasing capacity, and enabling operation across a broader temperature range. These advancements allow for the safe use of higher charge voltages, making Silatronix's products suitable for various applications, including portable electronics, electric vehicles, and large-scale energy storage systems.
Phoenix
Venture Round in 2014
Phoenix, LLC, established in 2005 and headquartered in Madison, Wisconsin, specializes in designing and manufacturing high-yield neutron generators and other commercial nuclear technologies. These products cater to diverse applications across industries such as aerospace, defense, medical, and semiconductor, including neutron radiography, cargo screening, medical isotope production, and nuclear fuel scanning. The company's commitment to practical nuclear technologies has also set a long-term goal of contributing to clean, fusion energy production.
FluGen
Debt Financing in 2014
FluGen, Inc. is a biopharmaceutical company based in Madison, Wisconsin, focused on developing vaccines to prevent diseases caused by influenza viruses. Founded in 2007, FluGen specializes in both seasonal and pandemic influenza prevention. The company offers RedeeFlu, a nasal spray vaccine, and utilizes a vaccine-loaded intradermal microneedle delivery device. FluGen's innovative approach includes the use of a live, single replication, intranasally delivered virus with a deleted M2 segment (M2SR), enhancing its ability to prevent the spread of influenza and other respiratory pathogens, including COVID-19.
Madison Vaccines
Series A in 2014
Madison Vaccines, Inc. is a biopharmaceutical company based in the United States that specializes in the development of therapeutic plasmid DNA vaccines, specifically targeting prostate cancer and bone metastases. The company is engaged in creating two distinct vaccines aimed at treating prostate cancer and is also developing a diagnostic test to identify patients who would benefit from these therapies. Madison Vaccines' immune-activating therapies are designed to stimulate the immune system to eradicate residual tumor cells before they progress to overt bone metastases, thus delaying the need for castration therapies and improving the chances of a cure at an early stage of the disease.
Swallow Solutions
Funding Round in 2013
Swallow Solutions, LLC is a company based in Madison, Wisconsin, dedicated to addressing swallowing disorders, also known as dysphagia, in the United States. Founded in 2004, the company specializes in developing therapeutic devices and nutritional food products tailored to the specific needs of patients based on their diagnosed level of swallowing difficulty. One of its notable offerings is SwallowSTRONG, which features a custom-molded mouthpiece combined with software that enables speech-language pathologists to implement an evidence-based therapy regimen aimed at improving lingual strength. Additionally, Swallow Solutions provides a cloud-based management system that allows clinicians to remotely monitor patients' progress, adjust therapy parameters, and analyze therapy data. Through these innovative solutions, Swallow Solutions aims to enhance the quality of life for individuals with swallowing difficulties.
Silatronix
Venture Round in 2013
Silatronix, Inc. is a company that specializes in the development of organosilicon compounds and formulations for energy storage applications. Founded in 2007 and based in Madison, Wisconsin, Silatronix focuses on creating organosilicon electrolytes designed for use in rechargeable and non-rechargeable lithium-ion batteries, as well as in ultracapacitors. The company's patented materials enhance battery performance by extending cell life, increasing capacity, and enabling operation across a broader temperature range. These advancements allow for the safe use of higher charge voltages, making Silatronix's products suitable for various applications, including portable electronics, electric vehicles, and large-scale energy storage systems.
SOLOMO Technology
Series A in 2013
SOLOMO Technology Inc. is a mobile software company based in Madison, Wisconsin, that specializes in indoor location intelligence and personalized marketing solutions for retailers. Founded in 2010, the company offers a cloud-based platform known as SOLOMO Exchange, which connects to retailers' mobile applications to facilitate the secure exchange of customer identity and location data for personalized offers. This platform includes various tools such as SOLOMO Geo, which provides location-based notifications for employees and customers, and SOLOMO Identity, allowing customers to manage their personal data. Additionally, SOLOMO offers branded mobile applications that enable retailers to enhance customer engagement through targeted notifications and improved service from sales associates. By leveraging location intelligence analytics, SOLOMO Technology aims to create seamless, customized experiences that strengthen customer trust both in-store and online.
Swallow Solutions
Series A in 2013
Swallow Solutions, LLC is a company based in Madison, Wisconsin, dedicated to addressing swallowing disorders, also known as dysphagia, in the United States. Founded in 2004, the company specializes in developing therapeutic devices and nutritional food products tailored to the specific needs of patients based on their diagnosed level of swallowing difficulty. One of its notable offerings is SwallowSTRONG, which features a custom-molded mouthpiece combined with software that enables speech-language pathologists to implement an evidence-based therapy regimen aimed at improving lingual strength. Additionally, Swallow Solutions provides a cloud-based management system that allows clinicians to remotely monitor patients' progress, adjust therapy parameters, and analyze therapy data. Through these innovative solutions, Swallow Solutions aims to enhance the quality of life for individuals with swallowing difficulties.
Celleration
Venture Round in 2013
Celleration Inc. is a privately held medical device company based in Eden Prairie, Minnesota, founded in 1999. The company specializes in developing and commercializing therapeutic ultrasound technologies for wound care. Its flagship product, the MIST Therapy System, utilizes low-frequency ultrasound delivered through a saline mist to promote healing in wounds. This innovative approach allows ultrasound energy to penetrate beyond the surface of the wound, stimulating cellular activity and enhancing the healing process. Since receiving FDA clearance in 2005, Celleration has established a strong presence in the U.S. market, with over 1 million MIST Therapy treatments performed, benefiting more than 65,000 patients across numerous healthcare facilities. Celleration's commitment to advancing wound care technology has resulted in significant clinical and economic benefits, reinforcing its role in the medical community.
TermSync
Seed Round in 2012
TermSync is an accounts receivable automation platform based in Madison, Wisconsin. The company provides an online solution that enhances the management of payment term relationships, currently overseeing more than 2,000 such relationships with clients and their customers, with an impressive track record of over 99% of payments being made on or before the due date. TermSync offers a range of software features, including payment plans, payment options, payment assurance, early pay discounts, and services related to the credit application process, all aimed at streamlining accounts receivable processes for businesses.